Observational analysis shows Hsp70 promotes metastasis and invasion in lung cancer, indicating critical signaling pathways involved.
Purpose To investigate the effects and mechanisms of Hsp70-mediated regulation of CD24 expression on the invasion and metastasis of lung cancer. Methods Protein-protein interactions between Hsp70 and CD24 were analyzed by co-immunoprecipitation and immunofluorescence. Lentiviral-mediated Hsp70 knockdown and CD24 overexpression were validated using RT-qPCR and Western blotting. Functional consequences were assessed through CCK-8 proliferation assays, colony formation, wound healing, Transwell migration/invasion, and angiogenesis assays. In vivo metastatic potential was evaluated using a tail vein injection model in nude mice. Results Hsp70 and CD24 demonstrated interaction through co-precipitation. Knockdown of Hsp70 significantly attenuated CD24 expression (p<0.01), whereas CD24 overexpression did not alter Hsp70 levels. Phenotypically, Hsp70 suppression impaired cellular proliferation, migration, invasion and angiogenic capacity, while CD24 overexpression potentiated these oncogenic properties. Both manipulations modulated ERK1/2, MEK, Raf and Ras phosphorylation status. Conclusion Hsp70 upregulates CD24 expression and activates downstream MAPK/ERK signaling, thereby enhancing the metastatic and invasive capacity of lung cancer.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: